Dieter Ruppert

706 total citations
10 papers, 640 citations indexed

About

Dieter Ruppert is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Dieter Ruppert has authored 10 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Organic Chemistry and 4 papers in Molecular Biology. Recurrent topics in Dieter Ruppert's work include HIV/AIDS drug development and treatment (8 papers), Organophosphorus compounds synthesis (6 papers) and Click Chemistry and Applications (4 papers). Dieter Ruppert is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), Organophosphorus compounds synthesis (6 papers) and Click Chemistry and Applications (4 papers). Dieter Ruppert collaborates with scholars based in Germany and Slovakia. Dieter Ruppert's co-authors include Anusch Peyman, Karl‐Heinz Budt, Bernd Stowasser, Jianqi Li, Wilhelm Stahl, C Meichsner, Holger Heitsch, Arno Paessens, Rainer Henning and Walter Kocher and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Dieter Ruppert

10 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dieter Ruppert Germany 9 575 198 129 60 40 10 640
Karl‐Heinz Budt Germany 8 553 1.0× 188 0.9× 116 0.9× 64 1.1× 27 0.7× 10 611
Mark C. Allen United Kingdom 8 479 0.8× 100 0.5× 129 1.0× 20 0.3× 29 0.7× 15 554
Robert H. Lemus United States 8 264 0.5× 43 0.2× 144 1.1× 72 1.2× 25 0.6× 9 429
Lilia J. Kurz Poland 10 328 0.6× 58 0.3× 124 1.0× 51 0.8× 38 0.9× 11 431
Katherine Rielly-Gauvin United States 6 529 0.9× 207 1.0× 121 0.9× 18 0.3× 27 0.7× 6 570
Eric J. Stoner United States 10 323 0.6× 59 0.3× 115 0.9× 53 0.9× 10 0.3× 13 420
Chester Sapino United States 11 365 0.6× 37 0.2× 189 1.5× 74 1.2× 34 0.8× 15 524
Ruen Chu Sun Switzerland 6 227 0.4× 63 0.3× 131 1.0× 103 1.7× 10 0.3× 7 332
Céline Mordant France 8 187 0.3× 165 0.8× 116 0.9× 52 0.9× 9 0.2× 10 319
Wojciech Dąbkowski Poland 14 298 0.5× 62 0.3× 157 1.2× 25 0.4× 7 0.2× 51 382

Countries citing papers authored by Dieter Ruppert

Since Specialization
Citations

This map shows the geographic impact of Dieter Ruppert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dieter Ruppert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dieter Ruppert more than expected).

Fields of papers citing papers by Dieter Ruppert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dieter Ruppert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dieter Ruppert. The network helps show where Dieter Ruppert may publish in the future.

Co-authorship network of co-authors of Dieter Ruppert

This figure shows the co-authorship network connecting the top 25 collaborators of Dieter Ruppert. A scholar is included among the top collaborators of Dieter Ruppert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dieter Ruppert. Dieter Ruppert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Budt, Karl‐Heinz, Anusch Peyman, Jochen Knolle, et al.. (1995). HIV protease inhibitor HOE/BAY 793, structure-activity relationships in a series of C2-symmetric diols. Bioorganic & Medicinal Chemistry. 3(5). 559–571. 16 indexed citations
2.
Peyman, Anusch, et al.. (1994). Inhibition of human immunodeficiency virus-1 protease by a C2-symmetrical phosphinic acid amide. Bioorganic & Medicinal Chemistry Letters. 4(10). 1191–1194. 8 indexed citations
3.
Peyman, Anusch, et al.. (1994). Non-peptide-based inhibitors of human immunodeficiency virus-1 protease. Bioorganic & Medicinal Chemistry Letters. 4(21). 2601–2604. 59 indexed citations
4.
Peyman, Anusch, et al.. (1994). ChemInform Abstract: Phosphinic Acid‐Based C2‐Symmetrical Inhibitors of HIV‐Protease.. ChemInform. 25(14). 1 indexed citations
5.
Peyman, Anusch, et al.. (1993). Phosphinic Acid‐Based C2‐Symmetrical Inhibitors of HIV‐Protease**. Angewandte Chemie International Edition in English. 32(12). 1720–1722. 33 indexed citations
6.
Peyman, Anusch, et al.. (1993). C2‐symmetrische Inhibitoren der HIV‐Protease auf Phosphinsäurebasis. Angewandte Chemie. 105(12). 1852–1854. 12 indexed citations
7.
Schramm, Hans J., Gerhard Breipohl, Stephan Henke, et al.. (1992). Inhibition of HIV-1 protease by short peptides derived from the terminal segments of the protease. Biochemical and Biophysical Research Communications. 184(2). 980–985. 11 indexed citations
8.
Heitsch, Holger, Rainer Henning, Werner Kramer, et al.. (1992). Renin inhibitory pentols showing improved enteral bioavailability. Journal of Medicinal Chemistry. 35(3). 559–567. 26 indexed citations
9.
Peyman, Anusch, et al.. (1992). C2-symmetric phosphinic acid inhibitors of HIV protease. Tetrahedron Letters. 33(32). 4549–4552. 99 indexed citations
10.
Stowasser, Bernd, Karl‐Heinz Budt, Jianqi Li, Anusch Peyman, & Dieter Ruppert. (1992). New hybrid transition state analog inhibitors of HIV protease with peripheric C2-symmetry. Tetrahedron Letters. 33(44). 6625–6628. 375 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karl‐Heinz Budt Breakdown of academic impact, for papers by Mark C. Allen Breakdown of academic impact, for papers by Robert H. Lemus Breakdown of academic impact, for papers by Lilia J. Kurz Breakdown of academic impact, for papers by Katherine Rielly-Gauvin Breakdown of academic impact, for papers by Eric J. Stoner Breakdown of academic impact, for papers by Chester Sapino Breakdown of academic impact, for papers by Ruen Chu Sun Breakdown of academic impact, for papers by Céline Mordant Breakdown of academic impact, for papers by Wojciech Dąbkowski
Rankless by CCL
2026